NBIX vs SM · P/E 45, rev $1.77B vs P/E 3.6, rev $3.98B
Neurocrine Biosciences Inc (NBIX) versus SM Energy Co (SM) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
SM Energy Co (SM) is a oil & gas e&p company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SM revenue for 2026-06-30 was $3.98B. Net income was $736.0M. SM currently screens at market cap $2.97B and trailing P/E 3.6.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SM currently screens at market cap $2.97B and trailing P/E 3.6.
Not investment advice. Open the NBIX and SM stock pages for the full models.
Not investment advice.